Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
In the proposed study, the investigators plan to evaluate the efficacy and safety of
Cefotaxime sodium and sulbactam sodium for injection (2:1)for the treatment of respiratory
and urinary tract acute bacterial infection under the widely used in clinical conditions.